Home › Lung Cancer › Texas › Tyler
Lung Cancer clinical trials in Tyler, TX
4 studies for Lung Cancer are looking for participants at sites in and around Tyler (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecruitingPhase 1/2
- The University of Texas Health Science Center at Tyler, Tyler
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RecruitingPhase 3
- University of Texas Health Center at Tyler, Tyler
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Texas Oncology - Northeast Texas, Tyler
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
RecruitingObservational study
- CHRISTUS Trinity Mother Frances Health System, Tyler
About Lung Cancer
Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
More about Lung Cancer on MedlinePlus
Lung Cancer trials in other cities
- Houston, TX78 studies
- Boston, MA63 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Chicago, IL43 studies
- Arlington, VA42 studies
- Washington, DC41 studies
- Baltimore, MD41 studies
- Nashville, TN39 studies
- St. Louis, MO37 studies
- Columbus, OH36 studies
- Philadelphia, PA36 studies
Other studies in Tyler
- Non-Small Cell Lung Cancer19 studies
- Crohn's Disease16 studies
- Ulcerative Colitis13 studies
- Ovarian Cancer9 studies
- Colorectal Cancer8 studies
- Heart Failure8 studies
- Cancer (all types)7 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Endometrial Cancer6 studies
- Atrial Fibrillation6 studies
- Breast Cancer5 studies
- Metastatic Cancer5 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.